PAHA model: an alternative non-invasive predictor of liver cirrhosis in patients with chronic hepatitis B infection.
Oyekoya T
OT
Ayonrinde
John K
JK
Olynyk
D016632:Apolipoprotein A-I / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D018450:Disease Progression; D006242:Haptoglobins / Q000032:analysis; D019694:Hepatitis B, Chronic / Q000097:blood / Q000150:complications* / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology / Q000821:virology; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis* / Q000473:pathology / Q000821:virology; D008954:Models, Biological; D010976:Platelet Count; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors
C505693:APOA1 protein, human; D016632:Apolipoprotein A-I; D015415:Biomarkers; D006242:Haptoglobins; D001219:Aspartate Aminotransferases